1-1 of 1
propranolol
Close
Sort by
Journal Articles

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Clinical Trials & Observations
Jennifer M. Knight, J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza, Brent R. Logan, Mehdi Hamadani, Saurabh Chhabra, Binod Dhakal, Nirav Shah, Deepika Sriram, Mary M. Horowitz, Steve W. Cole
Journal: Blood Advances
Blood Adv (2020) 4 (3): 467–476.
https://doi.org/10.1182/bloodadvances.2019000765
Published: 2020
Includes: Supplemental data